Open Orphan plc operates as a clinical research organization pharmaceutical services company with a focus on virology, vaccine studies, and
orphan drugs in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. It operates a virtual rep, a pharmaceutical commercialization platform for rare/orphan disease space; and develops Genomic Health Data platform, a collection of infectious disease progression data. The company also provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations. In addition, it offers hVIVO COVID Clear Test, an antibody test for employers in the United Kingdom and Ireland. The company is headquartered in London, the United Kingdom. The company trades on AIM exchange marketplace. The company headquarter is located in United Kingdom. The company was established in the 2012. As of writing, the company status seems to be inactive, which indicates it may not be actively trading on the stock exchanges and may be delisted/merged/suspended/renamed.
| Ticker | ORPH |
| Long Name | Open Orphan PLC |
| Short Name | Open Orphan |
| Sector | Healthcare |
| Subsector | Biotechnology |
| Subsector 2 | Health Care |
| Currency | GBX |
| ISIN | |